PhoreMost and ThinkCyte partner to develop AI-based drug discovery
The partnership combines systems in order to identify subtle phenotypic changes in living cells
Read More
Tag: PhoreMost
PhoreMost enters multi-target collaboration with Arvinas
PhoreMost to deploy its Siteseeker protein platform to enable drug discovery
Read More
PhoreMost in drug target discovery collaboration with Roche
PhoreMost will use Siteseeker platform to identify novel targets for Roche’s discovery programmes
Read More
Cambridge start-up PhoreMost raises £33m to progress PLK1 programme
Lead ‘Allosteric PLK1’ asset will initially target brain cancer
Read More
PhoreMost enlists Otsuka in multi-project drug discovery collab
The partnership will have an initial focus on gene therapy applications of identified targets.
Read More
PhoreMost, C4X Discovery announce neurodegeneration collaboration
The collaboration will initially accelerate C4X Discovery’s Parkinson’s disease drug discovery pipeline.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
